# Primogene

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/primogene

- Industry: Biotechnology
- Headquarters: Leipzig, Germany
- Website: www.primogene.bio
- Total disclosed funding: $4.8M
- Latest round: Seed (Aug 14, 2025)
- Investors on record: 7

## About

Based in Germany, Primogene GmbH develops and manufactures innovative functional ingredients that cater to diverse consumer needs in health and nutrition.Primogene GmbH, founded in 2023 in Leipzig, Germany, focuses on creating specialized ingredients for the nutrition and personal care sectors. The company was co-founded by Ing. Reza Mahour (CEO), Valerian Grote (CTO), and Linda Karger (COO). In August 2025, Primogene GmbH raised EUR 4.1 million in seed funding led by High-Tech Gruenderfonds, with participation from CFH Management, SBC, better ventures, Golzern Holding, CF Equity GmbH and FS Life Science Investment. Primogene specializes in the development and manufacturing of innovative functional ingredients that support various life stages, from infancy to senior years. The company’s core offerings include microbiome-friendly active ingredients for personal care and specific nutritional formulations tailored to diverse dietary needs, serving a broad customer base including manufacturers in the nutrition sector, personal care formulators, and research institutions. Primogene primarily markets its products in North America and Europe, focusing on regions with high consumer demand for nutritional and personal care solutions.Primogene's revenue model relies on B2B transactions, partnering with manufacturers and retailers in the nutrition and personal care industries. The company engages in direct sales, providing customized solutions to meet client needs, often resulting in long-term bulk orders of its flagship products. This business structure enables Primogene to cultivate steady revenue streams through specialized ingredient supplies, with pricing reflecting the innovative nature of its offerings.In August 2025, Primogene GmbH raised EUR 4.1 million in Seed funding, aiming to enhance production capacity, augment its intellectual property portfolio, expand its team, and diversify its customer base. The funding will also assist in forging new strategic partnerships. Primogene plans to introduce new products designed to meet evolving consumer health demands and is targeting expansion into additional markets across North America and Europe as part of its growth strategy.

## Funding rounds

- Seed, Aug 14, 2025, $4.8M — CFH Management, High-Tech Gruenderfonds, Golzern Holding, better ventures, CF Equity GmbH, FS Life Science Investment, SBG

## Investors

- CFH Management (https://capitalatlas.ai/funds/cfh-management) — Seed
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- Golzern Holding (https://capitalatlas.ai/funds/golzern-holding) — Seed
- better ventures — Seed
- CF Equity GmbH — Seed
- FS Life Science Investment (https://capitalatlas.ai/funds/fs-life-science-investment) — Seed
- SBG (https://capitalatlas.ai/funds/sbg) — Seed